🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test whether vaccination with antigenic pep...
Status
Completed
Location
Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois
Start Date
1999-05
Trial ID
NCT00112216
Treatments Being Tested
The aim of Neo-POLEM is to determine the rate of Major Pathological Respons...
Status
Terminated
Location
The Queen Elizabeth Hospital
Start Date
2025-06-16
Trial ID
NCT06692959
Treatments Being Tested
Title: IDO peptid vaccination in combination with immune stimulating agent ...
Status
Completed
Location
Center for Cancer ImmuneTherapy
Start Date
2010-06
Trial ID
NCT01219348
Treatments Being Tested
This study is a multi-center, double-blind, placebo-controlled, Phase I stu...
Status
Completed
Location
University of Iowa - Vaccine Research and Education Unit
Start Date
2016-07-05
Trial ID
NCT02743455
Treatments Being Tested
The incidence of melanoma is increasing with an estimated incidence of 59,9...
Status
Completed
Location
New York University Langone Medical Center
Start Date
2010-09
Trial ID
NCT01079741
Treatments Being Tested
This phase I trial studies the side effects and best dose of vaccine therap...
Status
Recruiting
Location
Indiana University Melvin & Bren Simon Comprehensive Cancer Center
Start Date
2025-01-17
Trial ID
NCT06414733
Treatments Being Tested
This study will evaluate the safety of administering a peptide vaccine cons...
Status
Completed
Location
Duke Comprehensive Cancer Center
Start Date
2007-03
Trial ID
NCT00437502
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of A...
Status
Completed
Location
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore
Start Date
2019-07-08
Trial ID
NCT04009824
Treatments Being Tested
This study will evaluate the safety and feasibility of administering a pept...
Status
Completed
Location
Duke Comprehensive Cancer Center
Start Date
2007-06
Trial ID
NCT00674791
Treatments Being Tested
This phase I trial studies the side effects and best dose of vaccine therap...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2011-06-21
Trial ID
NCT01376505
Treatments Being Tested